Newly Diagnosed Multiple Myeloma Completed Phase 2 Trials for Lenalidomide (DB00480)

Also known as: Newly Diagnosed Multiple Myeloma (NDMM) / Newly Diagnosed, Multiple Myeloma / Multiple Myeloma, Newly Diagnosed

IndicationStatusPhase
DBCOND0036257 (Newly Diagnosed Multiple Myeloma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01936532Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)Treatment